AUG 28, 2018 10:37 PM PDT

Alternative Therapy for Peripheral Artery Disease

WRITTEN BY: Nouran Amin

Image Credit: conehealth.com

To fight peripheral artery diseases (PAD), an “ailment affecting 8 million Americans”, researchers at LSU School of Veterinary Medicine have discovered two drugs found in red wine that may serve as an alternative treatment: resveratrol and quercetin.

These particular drugs hold beneficial effects on arterial cells, such as healing, without any adverse side effects commonly seen in PAD therapies. The researcher’s goal was to use drugs that do not pose a threat to cells but rather restrict them from growing and narrowing an artery. "Dr. Dugas discovered that these two drugs in combination worked well for that purpose," said Crisitna Sabliov, LSU Biological and Agricultural Engineering professor. "She found the right potion, but she wanted the drugs released over time, and for that, she needed a smart delivery system. To be able to do that, Assistant Research Professor Carlos Astete and myself loaded these drugs into a nanoparticle," says Sabliov. "Nanoparticles are really, really small -- only 100-200 nanometers (nm). In comparison, a hair is 70,000 nm thick."

Researchers will seek to develop a drug-coated balloon (DCB) therapy where red wine compounds are sprayed evenly on the outside of a balloon in a nanoparticle can adhere to vessel walls, releasing the compound and preventing the growth of cells and narrowing of vessels to allow blood. "The whole procedure takes only a few minutes, so we need to make sure the particles are released from the balloon very quickly," said Sabliov.

However, research is never simple: "We have some challenges because, number one, you want the drugs released over time," Sabliov said. "And number two, the two different chemicals have to be in the optimum ratio that she [Dugas] finds works best. If they have a positive charge, then they attach quickly to the cells. "The ratio must be 1:2 because that's the magic potion that will make the drugs effective. We didn't want the drugs to kill the cells. We just wanted them to prevent the cells from growing back."

Learn more about peripheral artery disease (PAD):

Source: Louisiana State University, Journal of Biomedical Materials

About the Author
  • Nouran enjoys writing on various topics including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
OCT 18, 2018
Drug Discovery
OCT 18, 2018
Potential Drug Target for Tactile Allodynia
According to research published in the journal Science Translational Medicine in collaboration with a study led by the National Institutes of Health, a new...
OCT 31, 2018
Drug Discovery
OCT 31, 2018
New Drug Target For a Rare Lymphoma
The promise of immunotherapy in oncology is stronger than ever. Now, an international team of scientists and physicians from the Research Institute of the ...
NOV 08, 2018
Health & Medicine
NOV 08, 2018
Is Daily Aspirin Safe For Heart Attack Prevention
The benefits of aspirin use in patients with known cardiovascular disease (CVD) are well-established. A 2015 meta-analysis reviewed data gathered from 118,...
NOV 05, 2018
Microbiology
NOV 05, 2018
Potential Antidote to Botulism is Found
A microbe called Clostridium botulinum and sometimes two other strains of Clostridium bacteria can make a toxic chemical called botulism....
FEB 01, 2019
Drug Discovery
FEB 01, 2019
Re-purposing Anti-rejection Drug for Liver Cancers
Scientists at the University of Pittsburgh School of Medicine have identified a molecular pathway in liver that can allow an anti-rejection drug to be repu...
FEB 17, 2019
Drug Discovery
FEB 17, 2019
Drug Improves Muscle Properties
Currently, adults over 65 are an increasingly growing segment in many countries. In the United States, the elderly population will increase by 40 percent w...
Loading Comments...